ArticleComplementary medicine research2026
Shengmai Liquid (Chinese Patent Medicine) for the Treatment of Post-COVID-19 Fatigue: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.
Jia-Xin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.